Application 209139
- Type
- NDA
- Sponsor
- CARMEL BIOSCIENCES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 20MG/5ML | Yes | No |
| 002 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 80MG/20ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209139-001 | PREXXARTAN | VALSARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N209139-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | AB | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan | VALSARTAN | Aphena Pharma Solutions - Tennessee, LLC | 5a816ea6-2645-bd6e-e063-6294a90a908b | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | Jubilant Cadista Pharmaceuticals Inc. | 9402b022-5809-4251-dfef-54f6ef5723fe | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Aphena Pharma Solutions - Tennessee, LLC | 59d3db05-2d63-9dbf-e063-6394a90a8dd3 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Diovan | VALSARTAN | Novartis Pharmaceuticals Corporation | 5ddba454-f3e6-43c2-a7a6-58365d297213 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| VALSARTAN | VALSARTAN | Ohm Laboratories Inc. | ab5e0e5a-5bdf-4cfc-9d18-57ea4d642f65 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Macleods Pharmaceuticals Limited | 251ccff4-bf86-453b-9d1c-e3c1ecfd3a46 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | 7aaa0a16-d7c6-4952-aa27-0b4b8982dc5f | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | ScieGen Pharmaceuticals, INC. | 1a8af3d9-4053-4233-82a7-e8c7bc9e302f | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | A-S Medication Solutions | bb3c66a7-d397-4df5-822f-4a1f797f54fc | 2026-07-13 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | 04b3301f-e054-ed5d-e063-6294a90a819c | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | 04b3c573-4ef7-5cf6-e063-6294a90a2c5f | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | 6e9c4c57-e2c9-461b-9c09-669d3ada4c1a | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | 7cb9f284-8175-4679-b846-145dc604e2c0 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | c12db287-786c-47ae-a1f3-df04ddfd2a70 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | b3880f58-ce15-4701-84aa-8eb185cf43e2 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | 7b523502-62b3-425e-960b-f0a58919d3ec | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Laurus Labs Limited | 6e1f63ad-e554-421b-a699-4e8c9bd4d239 | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | A-S Medication Solutions | 0925a24f-6a72-4c77-b4e6-0a8f5b12c8d0 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | PD-Rx Pharmaceuticals, Inc. | 4d6e85d8-7d51-4447-b43d-c2a77f4fe3ae | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Camber Pharmaceuticals, Inc. | d6e84105-9394-4ef0-928c-20d07d3fbaa9 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25208-100 | PREXXARTAN | PREXXARTAN | Medicure International Inc. | NDA | Current |